statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	990
SG - Singapore	210
PL - Polonia	155
CN - Cina	114
VN - Vietnam	59
IT - Italia	54
DE - Germania	44
GB - Regno Unito	44
BR - Brasile	37
TR - Turchia	29
HK - Hong Kong	28
UA - Ucraina	27
FI - Finlandia	22
FR - Francia	21
SE - Svezia	21
JP - Giappone	13
AT - Austria	12
ID - Indonesia	12
BE - Belgio	11
CA - Canada	11
IN - India	9
MX - Messico	9
RU - Federazione Russa	9
AR - Argentina	8
BD - Bangladesh	6
AU - Australia	5
IQ - Iraq	4
MA - Marocco	4
EC - Ecuador	3
VE - Venezuela	3
EG - Egitto	2
ES - Italia	2
LT - Lituania	2
NL - Olanda	2
NO - Norvegia	2
PH - Filippine	2
RO - Romania	2
SA - Arabia Saudita	2
TW - Taiwan	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BG - Bulgaria	1
BO - Bolivia	1
CG - Congo	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
HR - Croazia	1
IE - Irlanda	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
LV - Lettonia	1
MT - Malta	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PK - Pakistan	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.023

Nome	#
Altered motor phenotype and dopamine transmission associated with mutations of the parkinsonian gene LRRK2	320
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain	272
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice	261
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease	221
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain	217
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging	211
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes	210
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter	149
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex	112
null	77
Totale	2.050

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	57	0	0	0	0	0	0	0	0	0	27	20	10
2021/2022	114	2	7	10	3	8	20	7	8	7	5	12	25
2022/2023	138	10	14	11	12	30	16	8	11	12	0	9	5
2023/2024	73	13	5	4	0	6	8	3	11	2	2	1	18
2024/2025	248	5	6	29	10	24	29	2	4	55	23	35	26
2025/2026	763	97	16	53	117	121	60	112	36	82	69	0	0
Totale													2.050

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara